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Abstract
In 12 patients with affective disorders (ICD-10: F31, F32,
F33), EEGs were recorded before and after 4.4 months of
lithium treatment. Effects of lithium on the EEG were
analyzed by power spectral analysis controlled for vigi-
lance. We found (1) an increase in relative power in both
delta and theta band which was related to the lithium
plasma level, (2) a decrease in relative alpha power espe-
cially at occipital leads and (3) a reduction of the domi-
nant alpha frequency. The changes in relative power
were more pronounced in the right hemisphere, which is
in contrast to the hypothesis of a site-specific localization
of lithium effects only in left anterior regions.
Copyright © 2000 S. Karger AG, Basel
Introduction
The salt lithium was introduced in prophylaxis and
treatment of affective disorders in 1949. However, it is
well known that neurological side effects like tremor, atax-
ia, seizures or EEG alterations occur even when using lith-
ium at therapeutic levels.
Starting with the first report of lithium-induced
changes in EEG in 1949 [1], a number of studies using
visual analysis of the EEG reported a reduction in alpha
waves, an increase in delta and theta waves, an increase in
paroxysmal activity and abnormalities in vigilance [2–4].
Studies using quantitative EEG analysis described almost
consistently an increase of power in total, delta and theta
bands and a slowing of dominant alpha frequency [5–10].
Furthermore a focussing of lithium effects in left anterior
regions with intermitting slow waves is being discussed by
Ulrich [11].
These findings are inconsistent and partly contradicto-
ry. The studies are barely comparable among each other
because of the different recording and analysis methods,
the different sample characteristics (healthy volunteers,
bipolar or unipolar patients) and different medication
aspects (lithium intoxication, lithium monotherapy and
lithium combined with neuroleptics).
The purpose of our study was first to evaluate the
effects of lithium on relative power, dominant frequencies
and absolute power of the EEG spectra, controlled for
vigilance, in the course of long-term lithium treatment in
patients with affective disorders. Secondly, we were inter-
ested whether the hypothesis of site-specific effects of lith-
ium in the left frontal region is replicable using quantita-
tive EEG analysis.
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Table 1. Description of the studied patients with affective disorders
Patient data n 12
Age 59B13 years
Sex (F/M) 5/7
ICD-10 F31: n = 1
F32: n = 2
F33: n = 9
T1 T2
4.2B1.4 2.5B0.8
Analyzed 2-second EEG segments 52B16 52B18
Medication
AD (number of patients) 9 9
NL 3 –
No medication 3 –
Lithium plasma level – 0.67B0.17 mmol/l
AD = Antidepressives; NL = neuroleptics.
Table 2. Relative power of the EEG data at T1 (before lithium treat-
ment) and T2 (under lithium treatment)
Electrode
position
Mean T1
%
Mean T2
%
Wilcoxon
test
F3-C3 11.4B7.2 11.9B11.5 n.s.
F4-C4 10.7B8.4 13.1B12.7 n.s.
C3-P3 8.4B5.4 10.5B7.4 n.s.
C4-P4 6.9B3.1 9.6B6.5 0.06
P3-O1 9.1B9.5 10.7B8.8 n.s.
P4-O2 8.6B6.9 11.9B10.9 n.s.
Theta F3-C3 18.9B8.2 21.8B9.2 n.s.
F4-C4 16.8B7.2 21.5B7.6 0.02
C3-P3 17.6B6.1 23.0B9.8 0.04
C4-P4 15.4B5.3 24.0B11.1 0.00
P3-O1 16.5B9.2 23.6B10.4 0.02
P4-O2 16.6B7.6 23.0B10.3 0.02
Alpha F3-C3 38.1B20.2 39.1B20.7 n.s.
F4-C4 39.5B19.7 39.3B21.4 n.s.
C3-P3 55.5B13.7 50.6B16.8 0.07
C4-P4 59.2B12.9 51.3B16.7 0.02
P3-O1 59.0B22.4 52.8B19.3 0.04
P4-O2 58.4B20.0 52.4B20.9 0.03
Beta F3-C3 31.5B19.5 27.2B21.5 n.s.
F4-C4 33.0B20.2 26.0B15.5 0.08
C3-P3 18.4B6.8 16.0B4.8 n.s.
C4-P4 18.5B6.7 15.0B6.1 0.06
P3-O1 15.4B11.0 12.9B3.6 n.s.
P4-O2 16.5B11.6 12.7B3.8 n.s.
Method
EEG was obtained from 12 patients with affective disorders
(ICD-10: F31, F32, F33) of the Outpatient Clinic for Relapse Pro-
phylaxis in Affective Disorders who were included in a prospective
study. EEG was recorded before lithium treatment (T1) and 4.4 B
3.5 months after baseline under lithium (T2). The patients had ana-
lyzable recordings for quantitative EEG analysis at both time points.
The age of the patients (5 females, 7 males) ranged from 38 to 76
years (mean 59 B 13 years). Before lithium treatment (T1), 3
patients were treated with neuroleptics and antidepressants, 6 pa-
tients had antidepressive treatments without other psychotropic
drugs, and 3 patients were not treated with any psychotropic medica-
tion. At T2, 3 patients were only treated with lithium, and 9 patients
received additional antidepressive medication (table 1).
For EEG recording, patients were seated with eyes closed in a
comfortable chair located in a quiet room. Digital EEG was recorded
by electrocaps with the international 10/20 configuration and by use
of Cz as reference. The recordings were amplified and filtered by the
BEST system with a low-pass filter of 70 Hz and a high-pass filter of
0.5 Hz; the sampling rate was 256 Hz. For quantitative EEG analysis,
two experienced neurophysiologists visually selected artifact-free 2-
second segments (52 B 16 segments at T1, 52 B 18 segments at T2),
controlled for vigilance. At least 50% occipital alpha rhythm had to
be present in each segment.
Fast Fourier transformation was performed in the BEST system
for bipolar electrode pairs F3-C3, F4-C4, C3-P3, C4-P4, P3-O1 and P4-
O2. Absolute and relative power, and the dominant frequency for
delta (2–3.5 Hz), theta (3.5–8 Hz), alpha (8–12 Hz) and beta bands
(12–32 Hz) were calculated and statistically compared for T1 and T2,
using nonparametric Wilcoxon tests.
The lithium plasma level was correlated (Pearson correlation
coefficients) with relative theta and relative alpha power at T2, with
the difference in relative theta and relative alpha power between T1
and T2 and with the dominant frequency in the alpha band at T2.
Results
A significant increase of relative power under lithium
treatment was found in the theta band at all electrode
positions (F4-C4, C3-P3, C4-P4, P3-O1 and P4-O2) except
for left frontocentral F3-C3 (table 2). A strong increase in
relative theta power from T1 to T2 was related to a high
lithium plasma level (F3-C3: r = 0.81, p ! 0.01; F4-C4: r =
0.61, p ! 0.05). In the alpha band, the relative power was
unchanged at F3-C3 and F4-C4 and reduced at the central-
parieto-occipital electrodes (C4-P4, P3-O1 and P4-O2). Fig-
ure 1 shows that relative theta power at C4-P4 increased by
8.6% and relative alpha power decreased by 7.9% under
lithium treatment. The relative power in the delta band
was slightly increased at all electrodes without statistical
significance. The relative power of the beta band was gen-
erally reduced, but also without statistical significance.
The analysis of the dominant frequency revealed a gen-
eral slowing of the EEG in the total band at the electrodes
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Fig. 1. Changes in relative theta and alpha power at electrode pair
C4-P4 before and under lithium treatment.
Fig. 2. Changes in the dominant frequency of the alpha band before
and under lithium treatment. For each electrode position, the aver-
aged dominant frequency is displayed.
C4-P4 and P4-O2 under lithium therapy. The dominant
alpha frequencies were significantly slower at leads F3-C3,
F4-C4, C3-P3, C4-P4 and P4-O2, except for P3-O1 (fig. 2).
Figure 3 presents the power spectra of 1 patient, demon-
strating the slowing of the dominant alpha frequency
under long-term lithium treatment. In the delta, theta and
beta bands, no significant changes of the dominant fre-
quency were found.
A statistically significant increase in absolute power
was only found in the theta band at F3-C3, F4-C4, C3-P3,
C4-P4 and P3-O1.
Discussion
The aim of our study was to examine the effects of
long-term treatment with lithium on the EEG in patients
with affective disorders. Increased relative theta power
and decreased relative alpha power under lithium treat-
ment were found for both hemispheres with slightly high-
er significance for the right hemisphere. In addition, a sig-
nificant correlation between lithium plasma level and
increase of the theta power from T1 to T2 was found.
Slowing of the dominant frequency in the alpha band was
observed at all leads except the left occipital electrode.
Taking these findings together, the hypothesis of typical
EEG alterations in anterior regions of the left hemisphere
[11] cannot be supported. It seems more likely that lithi-
um affects the CNS without any preference of region. This
corresponds well to findings on the way of action of lithi-
um, indicating that lithium acts unspecifically on neuron-
al cells in the whole brain by influencing second-messen-
ger mechanisms.
It is unlikely that our above-mentioned findings are the
result of improved psychopathology. The CGI score of the
patients improved by 1.7 points from T1 to T2. Studies
concerning the EEG of depressive patients described en-
hanced delta, theta and alpha activity compared to nor-
mals [12–14]. Thus, with improvement in psychopatholo-
gy, an acceleration of the dominant alpha frequency com-
bined with an increase in relative alpha power and a
decrease in relative theta activity has to be expected. With
respect to the improvement in our group of patients in the
CGI score, we had to expect a decrease of theta activity and
an increase of alpha power at T2 due to the psychopatholo-
gy. However, the outcome of our examination was the
opposite. At T2, we found increased relative theta power,
decreased relative alpha power and slowing of the domi-
nant alpha frequency at T2 under lithium therapy. There-
fore, these EEG effects seem to be induced by lithium.
On the other hand, the EEG alterations found in our
study could be the result of changes in the medication oth-
er than lithium. At baseline, 9 patients were treated with
antidepressants, 3 of them additionally with neuroleptics.
At T2, 9 patients under lithium treatment were still on
antidepressants, but none of the patients received neuro-
leptics anymore. Neuroleptic-induced EEG changes are
associated with an increase of slow activity in the delta
and theta band and a decrease of alpha activity [14, 15].
Stopping medication with neuroleptics should lead to a
1
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Fig. 3. Example of the EEG power spectrum
in 1 patient with affective disorder. The line
at 9.5 Hz and 8.5 Hz respectively indicates
the dominant alpha frequency before (a) and
under (b) lithium treatment.
decreased theta activity and an increased activity in the
alpha band. However, we did not find such changes in our
study. Under lithium treatment without any neuroleptic
additional medication, theta activity was found to be
increased and alpha activity was reduced. Because the
number of patients treated with antidepressants did not
vary from T1 to T2, the effects of this medication on the
EEG may be negligible. Thus, it is unlikely that the
changes in the EEGs of our patient group can be explained
by changes in neuroleptic or antidepressive medication.
Furthermore, the correlation between the lithium plas-
ma level and the increase in theta power is an additional
argument that the change in theta power observed in this
study was induced by lithium.
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